• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    5.58 Down 0.21(3.63%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.79
    Open:5.80
    Bid:5.57 x 100
    Ask:5.90 x 100
    1y Target Est:13.92
    Beta:3.1
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:5.44 - 5.84
    52wk Range:5.06 - 12.88
    Volume:824,338
    Avg Vol (3m):1,396,540
    Market Cap:242.95M
    P/E (ttm):N/A
    EPS (ttm):-1.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTX

    Comparison

    Symbol% ChgMkt Cap
    PTXDown 3.63%242.95M
    JNJDown 0.03%272.98B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):5.12
    P/S (ttm):1.85
    Ex-Dividend Date:21-Aug-01

    Analysts

    Annual EPS Est (Dec-15) :0.36
    Quarterly EPS Est (Jun-15) :0.07
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):3.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback